New Strategy Discerns Early Stages Of HIV Infection, Paving Way For Targeted Study And Therapy

Researchers have devised a strategy for determining how long a person has been infected with HIV. And the finding, said one of the investigators, could revolutionize the approach to understanding early HIV infection, developing appropriate early treatments and estimating the incidence of HIV infection on a national scale.

The multi-institutional finding was reported in the July 1 special issue of JAMA. The general diagnostic approach will also be discussed in a number of sessions at the 12th World AIDS Conference in Geneva next week. The study was conducted by researchers at eight public and private institutions. The new tactic addresses what has been a major obstacle in the study and treatment of patients with HIV infection: the inability to determine how long a person has been infected with the virus, particularly in the early stages of infection.

Diagnosis is made when blood tests indicate that a person either carries the HIV virus or has antibodies to the virus. But these tests do not distinguish infection that occurred 10 days previously from infection that occurred 10 months before. As a result, scientists have not been able to study and tailor treatment to people with the earliest stages of the disease.

The researchers set out to overcome this roadblock. They modified the existing HIV test, called an enzyme immunoassay, to make it less sensitive than the original version. They then administered both tests to 579 people with HIV or AIDS. The result was that some people reacted only to the more sensitive form of the test. And these people, the researchers determined through subsequent study, had a more recent infection.

"This is the first test we've had that sensitively distinguishes patients with the very early stages of HIV from those with more advanced disease," said Margaret Chesney, PhD, a UCSF professor of medicine and co-director of the Center for AIDS Prevention Studies, part of the UCSF AIDS Research Institute (ARI) and a co-aut

Contact: Jennifer O'Brien
(415) 476-2557
University of California - San Francisco

Page: 1 2 3

Related biology news :

1. Strategy to treat AIDS patients in Africa with less drug, reduced toxicity set for clinical test
2. Dual Control Strategy Assures Accurate Cellular Marching Orders, But A Pathogenic Microbe Can Hijack The System
3. New Gene Therapy Strategy Keeps Muscles Strong In Old Age: Possibilities Seen For Disease Treatment, But Also For Athletic Or Cosmetic Enhancements
4. Novel Two-Antibody Strategy To Fight Cancer Awarded Patent
5. Inter-Element Recombination Between Retrotransposons May Be Strategy For Evolution Of Viruses Like HIV
6. Duke Researchers Call Gene Therapy A Promising Strategy For Sickle Cell Anemia
7. Pitt Researchers Develop Strategy To Use Dendritic Cells To Treat And Prevent Tumors
8. Recombinant Protein Immunizes Mice, Promises New Strategy Against Infection And Cancer
9. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
10. Early detection hope for eye disease
11. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find

Post Your Comments:

(Date:1/20/2019)... ... ... As the leader in 3D cell culture characterization and analysis, Visikol is ... culture models. In an effort to build a consensus in the market, Visikol will ... can replicate these models for their internal research efforts. , Recently, researchers have ...
(Date:1/20/2019)... ... 17, 2019 , ... The possibility that ethnic differences exist ... for many years. These observed differences may be manifest in alterations in safety, ... residing in different geographic regions. This created the perceived necessity to fully and ...
(Date:1/14/2019)... ... , ... Join the live session on Thursday, ... in data quality, including:, ,     State of the art solutions ... and wearable based performance measures ,     Data quality analytics ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... , ... January 29, 2019 , ... ... someone is frustrated over something like a tricky math problem on an online ... led by Worcester Polytechnic Institute (WPI) computer science assistant professor Erin Solovey ...
(Date:1/28/2019)... ... 2019 , ... Fragment-based lead discovery (FBLD) involves biophysical screening ... false positives can be problematic due to high levels of solvents and nonspecific ... highly sensitive to detect weak interactions. Nanomed , leading producer of graphene ...
(Date:1/24/2019)... ... January 23, 2019 , ... ... has awarded microbiome research support in study design, planning, sample collection, and analysis ... Sciences, St. Augustine Campus in Trinidad led by Dr. Elaine Monica Davis, MBBS, ...
(Date:1/20/2019)... (PRWEB) , ... January 17, 2019 , ... The American ... of its Patient Education program , a new initiative for 2019. Designed by ... designed to educate and inform patients, families, and the public on the status and ...
Breaking Biology Technology:
Cached News: